Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Fereshteh Ansari, Shohre Alian Samakkhah, Ali Bahadori, Seyedeh Maedeh Jafari, Mojtaba Ziaee, Mohammad Taghi Khodayari & Hadi Pourjafar. (2023) Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Critical Reviews in Food Science and Nutrition 63:4, pages 457-485.
Read now
Read now
Abbinaya Elangovan, Jessica R. Allegretti & Monika Fischer. (2019) Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opinion on Biological Therapy 19:12, pages 1343-1355.
Read now
Read now
Marco Lalle & Kurt Hanevik. (2018) Treatment-refractory giardiasis: challenges and solutions. Infection and Drug Resistance 11, pages 1921-1933.
Read now
Read now
Ener Cagri Dinleyici, Ates Kara, Metehan Ozen & Yvan Vandenplas. (2014) Saccharomyces boulardii CNCM I-745 in different clinical conditions. Expert Opinion on Biological Therapy 14:11, pages 1593-1609.
Read now
Read now
Annalisa Passariello, Pascal Agricole & Peter Malfertheiner. (2014) A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Current Medical Research and Opinion 30:6, pages 1055-1064.
Read now
Read now
Ener Cagri Dinleyici, Makbule Eren, Metehan Ozen, Zeynel Abidin Yargic & Yvan Vandenplas. (2012) Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opinion on Biological Therapy 12:4, pages 395-410.
Read now
Read now
Haendel GNO Busatti, Joseph FG Santos & Maria A Gomes. (2009) The old and new therapeutic approaches to the treatment of giardiasis: Where are we?. Biologics: Targets and Therapy 3, pages 273-287.
Read now
Read now
Articles from other publishers (35)
Nasrin Dashti & Mitra Zarebavani. (2021) Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes. Naunyn-Schmiedeberg's Archives of Pharmacology 394:9, pages 1869-1878.
Crossref
Crossref
Zunaira Iqbal, Shahzaib Ahmed, Natasha Tabassum, Riya Bhattacharya & Debajyoti Bose. (2021) Role of probiotics in prevention and treatment of enteric infections: a comprehensive review. 3 Biotech 11:5.
Crossref
Crossref
Elena Fekete, Thibault Allain, Affan Siddiq, Olivia Sosnowski & Andre G. Buret. (2021) Giardia spp. and the Gut Microbiota: Dangerous Liaisons. Frontiers in Microbiology 11.
Crossref
Crossref
Ana María Gil-Rodríguez & Enriqueta Garcia-Gutierrez. 2021.
37
72
.
Jana Alazzaz, Soraya Chaouch, Anne-Sophie Boucard, Luis G. Bermudez-Humaran & Isabelle Florent. 2020. Eukaryome Impact on Human Intestine Homeostasis and Mucosal Immunology. Eukaryome Impact on Human Intestine Homeostasis and Mucosal Immunology
335
349
.
Eman M. H. Méabed, Dalia N. Abdelhafez & Yasser F. Abdelaliem. (2019)
Saccharomyces boulardii
inhibits the expression of pro-inflammatory cytokines and inducible nitric oxide synthase genes in the colonic mucosa of rats experimentally-infected with
Blastocystis
subtype-3 cysts
. Parasitology 146:12, pages 1532-1540.
Crossref
Crossref
Jing-Jing Shen & Baochuan Guo. 2019. Pouchitis and Ileal Pouch Disorders. Pouchitis and Ileal Pouch Disorders
529
535
.
Abhijit Banik, Suman Kumar Halder, Chandradipa Ghosh & Keshab Chandra Mondal. 2019. Recent Advancement in White Biotechnology Through Fungi. Recent Advancement in White Biotechnology Through Fungi
101
117
.
Izabella Mogilnicka & Marcin Ufnal. (2018) Gut Mycobiota and Fungal Metabolites in Human Homeostasis. Current Drug Targets 20:2, pages 232-240.
Crossref
Crossref
M.R.S. RibeiroD.R. OliveiraF.M.S. OliveiraM.V. CaliariF.S. MartinsJ.R. NicoliM.F. TorresM.E.R. AndradeV.N. CardosoM.A. Gomes. (2018) Effect of probiotic Saccharomyces boulardii in experimental giardiasis. Beneficial Microbes 9:5, pages 789-798.
Crossref
Crossref
Ronald L. Koretz. (2018) Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?. American Journal of Gastroenterology 113:8, pages 1125-1136.
Crossref
Crossref
Luciana Laranjo Amorim Ventura, Dirce Ribeiro de Oliveira, Maria Aparecida Gomes & Marcia Regina Fantoni Torres. (2018) Effect of probiotics on giardiasis. Where are we?. Brazilian Journal of Pharmaceutical Sciences 54:2.
Crossref
Crossref
Sarah El Khoury, Andrée Rousseau, Alexandre Lecoeur, Bachar Cheaib, Sidki Bouslama, Pierre-Luc Mercier, Vanessa Demey, Mathieu Castex, Pierre Giovenazzo & Nicolas Derome. (2018) Deleterious Interaction Between Honeybees (Apis mellifera) and its Microsporidian Intracellular Parasite Nosema ceranae Was Mitigated by Administrating Either Endogenous or Allochthonous Gut Microbiota Strains. Frontiers in Ecology and Evolution 6.
Crossref
Crossref
Monika E. Jach & Anna Serefko. 2018. Diet, Microbiome and Health. Diet, Microbiome and Health
237
270
.
Renata Coltro Bezagio, Cristiane Maria Colli, Liara Izabela Lopes Romera, Érika Cristina Ferreira, Ana Lúcia Falavigna-Guilherme & Mônica Lúcia Gomes. (2016) Synergistic effects of fenbendazole and metronidazole against Giardia muris in Swiss mice naturally infected. Parasitology Research 116:3, pages 939-944.
Crossref
Crossref
L.V. McFarland. 2017. The Microbiota in Gastrointestinal Pathophysiology. The Microbiota in Gastrointestinal Pathophysiology
145
164
.
V. Choudhary, A. Vohra, A. Madan & Tulasi Satyanarayana. 2017. Yeast Diversity in Human Welfare. Yeast Diversity in Human Welfare
115
136
.
Luis Vitetta, Emma Saltzman, Tessa Nikov, Isabelle Ibrahim & Sean Hall. (2016) Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. Journal of Clinical Medicine 5:11, pages 102.
Crossref
Crossref
David R. Hill & Theodore E. Nash. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3154
3160.e3
.
Teresa Cristina Goulart Oliveira-Sequeira, Érica Boarato David, Cláudia Ribeiro, Semíramis Guimarães, Ana Paula Batista Masseno, Satie Katagiri & Julio Lopes Sequeira. (2014) EFFECT OF Bifidobacterium animalis ON MICE INFECTED WITH Strongyloides venezuelensis. Revista do Instituto de Medicina Tropical de São Paulo 56:2, pages 105-109.
Crossref
Crossref
Mariana Correa Franco, Marina A. Golowczyc, Graciela L. De Antoni, Pablo F. Pérez, Martín Humen & María de los Angeles Serradell. (2013) Administration of kefir-fermented milk protects mice against Giardia intestinalis infection. Journal of Medical Microbiology 62:12, pages 1815-1822.
Crossref
Crossref
Eric A. Johnson. (2012) Biotechnology of non-Saccharomyces yeasts—the ascomycetes. Applied Microbiology and Biotechnology 97:2, pages 503-517.
Crossref
Crossref
Carlos E Granados, Ludovic Reveiz, Luis G Uribe & Claudia P Criollo. (2012) Drugs for treating giardiasis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Luciana Farias da Costa de Avila, Fabricio Rochedo Conceição, Paula de Lima Telmo, Gisele Ferreira Dutra, Diego Gil de los Santos, Lourdes Helena Rodrigues Martins, Maria Elisabeth Aires Berne, Pedro Eduardo Almeida da Silva & Carlos James Scaini. (2012) Saccharomyces boulardii reduces infection intensity of mice with toxocariasis. Veterinary Parasitology 187:1-2, pages 337-340.
Crossref
Crossref
Theodoros Kelesidis & Charalabos Pothoulakis. (2011)
Efficacy and safety of the probiotic
Saccharomyces boulardii
for the prevention and therapy of gastrointestinal disorders
. Therapeutic Advances in Gastroenterology 5:2, pages 111-125.
Crossref
Crossref
Jürgen Stein & Axel Dignaß. (2012) Prävention und Therapie von entzündlichen Magen‐/Darm‐Erkrankungen. Pharmazie in unserer Zeit 41:2, pages 123-133.
Crossref
Crossref
Shakti Laishram, Gagandeep Kang & Sitara Swarna Rao Ajjampur. (2012) Giardiasis: A review on assemblage distribution and epidemiology in India. Indian Journal of Gastroenterology 31:1, pages 3-12.
Crossref
Crossref
Ashima Vohra & T. Satyanarayana. 2012. Microorganisms in Sustainable Agriculture and Biotechnology. Microorganisms in Sustainable Agriculture and Biotechnology
411
433
.
Ener Cagri Dinleyici, Makbule Eren, Nihal Dogan, Serap Reyhanioglu, Zeynel Abidin Yargic & Yvan Vandenplas. (2010) Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitology Research 108:3, pages 541-545.
Crossref
Crossref
Yvan Vandenplas, Genevieve Veereman-Wauters, Elisabeth De Greef, Tania Mahler, Thierry Devreker & Bruno Hauser. (2011) Intestinal Microbiota and Health in Childhood. Bioscience and Microflora 30:4, pages 111-117.
Crossref
Crossref
Marie-Agnès Travers, Isabelle Florent, Linda Kohl & Philippe Grellier. (2011) Probiotics for the Control of Parasites: An Overview. Journal of Parasitology Research 2011, pages 1-11.
Crossref
Crossref
. 2011. The Yeasts. The Yeasts
r1
r178
.
DAVID R. HILL & THEODORE E. NASH. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3527
3534
.
Jean-Paul Buts. (2008) Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives. Digestive Diseases and Sciences 54:1, pages 15-18.
Crossref
Crossref
. 2009. Emerging Issues and Controversies in Infectious Disease. Emerging Issues and Controversies in Infectious Disease
227
260
.